Industries > Pharma > Pharma Wholesale and Distribution Market Forecasts 2020-2030

Pharma Wholesale and Distribution Market Forecasts 2020-2030

Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW

PUBLISHED: 30 September 2019
PAGES: 217
PRODUCT CODE: PHA0526

Clear
WOOCS 2.2.1

The pharma wholesale and distribution market is estimated to grow at a CAGR of 5% in the first half of the forecast period. The market is estimated to reach a revenue of $1,447bn in 2025. In 2018, the branded drugs submarket held 78% of the pharma wholesale and distribution market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 135 charts– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the pharma wholesale and distribution market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharma Wholesale and Distribution Market from 2020-2030

• Forecast of the Global Pharma Wholesale and Distribution market by Category:
• Generic Drugs
• Branded Drugs
• Others

• This report provides individual revenue forecasts to 2030 for these national markets:
• US
• Germany
• France
• Italy
• Spain
• UK
• Japan
• China
• Brazil
• India
• Russia
• RoW

Pharma Wholesale and Distribution Market Forecasts 2020-2030

Each National Market is further segmented into generic drugs, branded drugs and others

• Our study discusses the selected leading companies that are the major players in the global pharma and wholesale distribution market:
• Alfresa Holdings
• AmerisourceBergen
• Cardinal Health
• CR Pharmaceuticals
• CuraScript SD
• McKesson
• Medipal Holdings Corporation
• Morris and Dickson
• Mutual Drug Company
• PHOENIX Group
• Shanghai Fosun Pharmaceuticals
• Sinopharm
• Suzuken
• Walgreens Boots Alliance

• This report provides a SWOT and STEP analysis of the pharma wholesale and distribution market.

Visiongain’s study is intended for anyone requiring commercial analyses for the pharma wholesale and distribution market. You find data, trends and predictions.

Buy our report today Pharma Wholesale and Distribution Market Forecasts 2020-2030: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Pharma Wholesale and Distribution Market Forecasts 2020-2030


Latest Pharma news

Pharmaceutical CDMO Services on the Rise

The pharmaceutical market is one of today’s fastest-growing industries, which is why the professionals from Visiongain have made it their business to help companies and stakeholders stay up to date. One sector experiencing significant growth is that of contract development and manufacturing organization (CDMO) services. Here you’ll find all you need to know about this fast-growing sector of the pharmaceutical …

24 February 2020

READ

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

READ

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

READ

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

READ

Categories

Category